BerandaONC • TSE
add
Oncolytics Biotech Inc
Tutup sebelumnya
$1,05
Rentang hari
$1,08 - $1,19
Rentang tahun
$0,98 - $2,08
Kapitalisasi pasar
91,22Â jt CAD
Volume Rata-Rata
152,76Â rb
Rasio P/E
-
Hasil dividen
-
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (CAD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 9,90Â jt | -10,40% |
Laba bersih | -9,54Â jt | 3,85% |
Margin laba bersih | — | — |
Penghasilan per saham | -0,12 | 10,29% |
EBITDA | -9,86Â jt | 10,56% |
Tarif pajak efektif | -0,13% | — |
Neraca
Total aset
Total liabilitas
| (CAD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 19,60Â jt | -50,98% |
Total aset | 24,26Â jt | -47,36% |
Total liabilitas | 15,20Â jt | -10,93% |
Total ekuitas | 9,06 jt | — |
Saham yang beredar | 77,07 jt | — |
Harga terhadap nilai buku | 8,75 | — |
Tingkat pengembalian aset | -87,86% | — |
Tingkat pengembalian modal | -167,51% | — |
Arus Kas
Perubahan kas bersih
| (CAD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -9,54Â jt | 3,85% |
Kas dari operasi | -4,83Â jt | 19,87% |
Kas dari investasi | -32,00Â rb | -100,47% |
Kas dari pembiayaan | -173,00Â rb | -100,81% |
Perubahan kas bersih | -5,25Â jt | -123,38% |
Arus kas bebas | -1,70Â jt | -171,09% |
Tentang
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Didirikan
1998
Kantor pusat
Karyawan
29
